| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Associated with liver metastasis risk and poor survival in colorectal cancer; suggested oncogenic role in CRC. |
| Molecular mechanism: |
- |
| Biological pathway or process: |
metastasis (other); other pathway/process (other) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Cohort Study; Survival Analysis; ROC Analysis; Bioinformatics Analysis |
| Clinical significance: |
High hsa_circ_0048122 is associated with liver metastasis and predicts poor overall survival in stage IV CRCLM; high expression predicts poor liver metastasis-free survival (LMFS) in early-stage CRC and may serve as a biomarker to predict metachronous liver metastasis. |
| Description: |
hsa_circ_0048122 is up-regulated in CRC tumor tissues and further elevated in liver metastases compared with primary CRC. High expression is associated with higher liver metastasis risk and predicts worse OS in CRCLM and worse LMFS in early-stage CRC, supporting its use as a biomarker for metachronous liver metastasis prediction. |
| Confidence score: |
0.5339 |